Psilocybin under anesthesia for depression
Treatments studied
Part of Mental health clinical trials.
This trial tests whether a single dose of psilocybin, given while you are under anesthesia, can help treat major depression. You will be monitored closely during and after the session.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 25 and 65 years old.
- You must have a current diagnosis of major depression (single or recurrent episode).
- You must be fluent in English and able to attend all study visits.
- You must not be taking most antidepressants or other medications that could interfere with the study drug.
- You must agree to avoid alcohol, cannabis, and other psychedelics for the entire study.
- You must be healthy enough to safely undergo general anesthesia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
This study tests whether psilocybin (a naturally occurring psychedelic compound) combined with therapy can help treat depression. Researchers will give you a single dose of psilocybin in a controlled medical setting while providing psychological support to see if it reduces your depression symptoms.
This trial tests whether a single dose of psilocybin can help people with treatment-resistant depression by changing how they focus on themselves. It aims to understand how psilocybin affects brain activity and self-related thinking.
This trial tests whether psilocybin can help people with major depression who are currently having a depressive episode. It aims to understand how the treatment works and if it is safe and effective.
This study tests if psilocybin (a psychedelic) combined with cognitive behavioral therapy (CBT) can help people with major depression. You would receive the psilocybin in a supervised setting and have talk therapy before and after.
This study tests whether psilocybin—a psychedelic compound—combined with group therapy can help people with depression. Participants receive guided psilocybin sessions at UCLA and attend group therapy to process the experience.
Hear when a new Major Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.